rs541513166

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_007194.4(CHEK2):​c.*76delT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CHEK2
NM_007194.4 3_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.62

Publications

0 publications found
Variant links:
Genes affected
CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
CHEK2 Gene-Disease associations (from GenCC):
  • CHEK2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • Li-Fraumeni syndrome 2
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acute myeloid leukemia
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary nonpolyposis colon cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007194.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHEK2
NM_007194.4
MANE Select
c.*76delT
3_prime_UTR
Exon 15 of 15NP_009125.1O96017-1
CHEK2
NM_001005735.3
c.*76delT
3_prime_UTR
Exon 16 of 16NP_001005735.1
CHEK2
NM_001438293.1
c.*76delT
3_prime_UTR
Exon 16 of 16NP_001425222.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHEK2
ENST00000404276.6
TSL:1 MANE Select
c.*76delT
3_prime_UTR
Exon 15 of 15ENSP00000385747.1O96017-1
CHEK2
ENST00000382580.6
TSL:1
c.*76delT
3_prime_UTR
Exon 16 of 16ENSP00000372023.2O96017-9
CHEK2
ENST00000402731.6
TSL:1
c.*76delT
3_prime_UTR
Exon 13 of 13ENSP00000384835.2A0A7P0MUT5

Frequencies

GnomAD3 genomes
AF:
0.00167
AC:
240
AN:
143536
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00102
Gnomad AMI
AF:
0.00116
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.000905
Gnomad EAS
AF:
0.00143
Gnomad SAS
AF:
0.00408
Gnomad FIN
AF:
0.00392
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00149
Gnomad OTH
AF:
0.00363
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000108
AC:
11
AN:
1018114
Hom.:
0
Cov.:
13
AF XY:
0.0000134
AC XY:
7
AN XY:
521942
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000400
AC:
1
AN:
24986
American (AMR)
AF:
0.00
AC:
0
AN:
38894
Ashkenazi Jewish (ASJ)
AF:
0.0000868
AC:
2
AN:
23036
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36528
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73976
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35916
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3342
European-Non Finnish (NFE)
AF:
0.00000952
AC:
7
AN:
735608
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45828
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.234
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00167
AC:
240
AN:
143654
Hom.:
0
Cov.:
32
AF XY:
0.00203
AC XY:
142
AN XY:
69848
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00101
AC:
40
AN:
39424
American (AMR)
AF:
0.00209
AC:
30
AN:
14386
Ashkenazi Jewish (ASJ)
AF:
0.000905
AC:
3
AN:
3314
East Asian (EAS)
AF:
0.00144
AC:
7
AN:
4876
South Asian (SAS)
AF:
0.00408
AC:
18
AN:
4412
European-Finnish (FIN)
AF:
0.00392
AC:
38
AN:
9706
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00149
AC:
96
AN:
64428
Other (OTH)
AF:
0.00359
AC:
7
AN:
1952
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.239
Heterozygous variant carriers
0
41
81
122
162
203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000273
Hom.:
0

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.6

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs541513166; hg19: chr22-29083808; API